Guggenheim Capital LLC Abbott Laboratories Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Guggenheim Capital LLC holds 124,704 shares of ABT stock, worth $16.4 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

124,704

Previous 151,395 17.63%

Holding current value

$16.4 Million

Previous $15.7 Million 9.62%

% of portfolio

0.1%

Previous 0.11%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $2.67 Million - $3.15 Million	-26,691 Reduced 17.63%	124,704 $14.2 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $1.05 Million - $1.17 Million	-10,443 Reduced 6.45%	151,395 $15.7 Million
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $498,096 - $550,126	4,548 Added 2.89%	161,838 $18.4 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $135,194 - $165,489	1,499 Added 0.96%	157,290 $17.3 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $2.09 Million - $2.51 Million	-21,919 Reduced 12.33%	155,791 $15.1 Million
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $3.8 Million - $4.24 Million	37,719 Added 26.94%	177,710 $19.4 Million
Q1 2023 May 10, 2023	BUY	$96.86 - $114.01 $4.2 Million - $4.95 Million	43,390 Added 44.92%	139,991 $14.2 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $1.95 Million - $2.29 Million	20,553 Added 27.03%	96,601 $10.6 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $1.07 Million - $1.24 Million	11,068 Added 17.03%	76,048 $7.36 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $7.35 Million - $8.89 Million	-72,040 Reduced 52.58%	64,980 $7.06 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $432,249 - $527,100	-3,791 Reduced 2.69%	137,020 $16.2 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $3.76 Million - $4.61 Million	32,570 Added 30.09%	140,811 $19.8 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $495,338 - $547,988	4,246 Added 4.08%	108,241 $12.8 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $2.51 Million - $2.96 Million	-23,738 Reduced 18.58%	103,995 $12.1 Million
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $857,876 - $1.01 Million	-7,882 Reduced 5.81%	127,733 $15.3 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $749,070 - $816,272	-7,134 Reduced 5.0%	135,615 $14.8 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $1.35 Million - $1.64 Million	-14,704 Reduced 9.34%	142,749 $15.5 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $1.62 Million - $2.08 Million	-21,219 Reduced 11.88%	157,453 $14.4 Million
Q1 2020 Jun 02, 2020	BUY	$62.82 - $91.86 $377,485 - $551,986	6,009 Added 3.48%	178,672 $14.1 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $1.12 Million - $1.25 Million	-14,245 Reduced 7.62%	172,663 $15 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $2.81 Million - $3.05 Million	-34,382 Reduced 15.54%	186,908 $15.6 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $727,633 - $848,640	-9,984 Reduced 4.32%	221,290 $18.6 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $2.6 Million - $3.15 Million	39,307 Added 20.48%	231,274 $18.5 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $6.32 Million - $7.16 Million	-96,381 Reduced 33.43%	191,967 $13.9 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $4.07 Million - $4.91 Million	66,912 Added 30.22%	288,348 $21.2 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $50.2 Million - $55.4 Million	-872,646 Reduced 79.76%	221,436 $13.5 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $14.6 Million - $16.5 Million	-259,062 Reduced 19.15%	1,094,082 $65.6 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $19.3 Million - $20.6 Million	358,637 Added 36.06%	1,353,144 $77.2 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $47.8 Million - $53.3 Million	994,507	994,507 $53.1 Million

Others Institutions Holding ABT

# of Institutions

3,265

Shares Held

1.31B

Call Options Held

9.64M

Put Options Held

8.27M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $230B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Abbott Laboratories Transaction History